New therapeutics and breast cancer: signal transduction inhibitors

被引：0

作者：

Campone, M. ^{[1
]}

机构：

[1] CLCC Rene Gauducheau, Inst Reg Cancerol Nantes Atlantique, Dept Med Oncol, F-44805 Nantes, France

来源：

ONCOLOGIE | 2007年 / 9卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S33 / S40

页数：8

共 51 条

[31]

MORENOASPITIA A, 2006, P AN M AM SOC CLIN, V24, P577

[32] Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer [J].

Pegram, MD ;

Konecny, GE ;

O'Callaghan, C ;

Beryt, M ;

Pietras, R ;

Slamon, DJ .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (10) :739-749

[33]

Perez EA, 2003, BREAST CANCER RES TR, V82, pS47

[34] Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer [J].

Piccart-Gebhart, MJ ;

Procter, M ;

Leyland-Jones, B ;

Goldhirsch, A ;

Untch, M ;

Smith, I ;

Gianni, L ;

Baselga, J ;

Bell, R ;

Jackisch, C ;

Cameron, D ;

Dowsett, M ;

Barrios, CH ;

Steger, G ;

Huang, CS ;

Andersson, M ;

Inbar, M ;

Lichinitser, M ;

Láng, I ;

Nitz, U ;

Iwata, H ;

Thomssen, C ;

Lohrisch, C ;

Suter, TM ;

Ruschoff, J ;

Süto, T ;

Greatorex, V ;

Ward, C ;

Straehle, C ;

McFadden, E ;

Dolci, MS ;

Gelber, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1659-1672

[35]

Ramaswamy B, 2003, BREAST CANCER RES TR, V82, pS50

[36] Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer [J].

Robert, Nicholas ;

Leyland-Jones, Brian ;

Asmar, Lina ;

Belt, Robert ;

Ilegbodu, Des ;

Loesch, David ;

Raju, Robert ;

Valentine, Elizabeth ;

Sayre, Robert ;

Cobleigh, Melody ;

Albain, Kathy ;

McCullough, Cecelia ;

Fuchs, Lea ;

Slamon, Dennis .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2786-2792

[37]

Robertson JFR, 2002, BREAST CANCER RES TR, V76, pS96

[38] Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer [J].

Romond, EH ;

Perez, EA ;

Bryant, J ;

Suman, VJ ;

Geyer, CE ;

Davidson, NE ;

Tan-Chiu, E ;

Martino, S ;

Paik, S ;

Kaufman, PA ;

Swain, SM ;

Pisansky, TM ;

Fehrenbacher, L ;

Kutteh, LA ;

Vogel, VG ;

Visscher, DW ;

Yothers, G ;

Jenkins, RB ;

Brown, AM ;

Dakhil, SR ;

Mamounas, EP ;

Lingle, WL ;

Klein, PM ;

Ingle, JN ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1673-1684

[39] Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development [J].

Rowinsky, EK ;

Windle, JJ ;

Von Hoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3631-3652

[40]

SALEH MN, 2003, P AN M AM SOC CLIN, V22, P829

← 1 2 3 4 5 6 →